BPG is committed to discovery and dissemination of knowledge
Articles Published Processes
Keyword: Polycythemia vera
1
Ropeginterferon Alfa-2b vs standard therapy in polycythemia vera: A meta-analysis of efficacy and safety outcomes
10/24/2025 6:10:14 AM | Browse: 21 | Download: 104
2
Cardiac hypertrophy in polycythemia vera: A case report and review of literature
10/31/2024 8:01:10 AM | Browse: 100 | Download: 580
3
Overview of dyslipidemia and metabolic syndrome in myeloproliferative neoplasms
6/24/2024 8:56:47 AM | Browse: 119 | Download: 558
4
Risk of hepatitis B reactivation in patients with myeloproliferative neoplasms treated with ruxolitinib
11/24/2023 6:10:12 AM | Browse: 320 | Download: 914
5
Acute myocardial infarction in myeloproliferative neoplasms
11/23/2023 8:41:51 AM | Browse: 245 | Download: 1014
6
Toxicity of targeted anticancer treatments on the liver in myeloproliferative neoplasms
9/22/2023 12:27:03 PM | Browse: 267 | Download: 843
7
Budd-Chiari syndrome in myeloproliferative neoplasms: A review of literature
3/20/2023 2:52:05 AM | Browse: 300 | Download: 1111
8
Minimal change disease caused by polycythemia vera: A case report
11/8/2022 7:44:25 AM | Browse: 476 | Download: 1442
9
Hemorrhagic transformation after acute ischemic stroke caused by polycythemia vera: Two case reports
8/31/2021 6:51:26 AM | Browse: 517 | Download: 1526
10
Recurrent thrombosis in the lower extremities after thrombectomy in a patient with polycythemia vera: A case report
12/19/2020 4:08:53 PM | Browse: 863 | Download: 2198
11
European vs 2015-World Health Organization clinical molecular and pathological classification of myeloproliferative neoplasms
8/20/2015 8:49:00 AM | Browse: 1474 | Download: 1812
12
PVSG and WHO vs European Clinical, Molecular and Pathological Criteria for prefibrotic myeloproliferative neoplasms
9/10/2014 2:25:00 PM | Browse: 1587 | Download: 1322
13
Aspirin responsive platelet thrombophilia in essential thrombocythemia and polycythemia vera
9/10/2014 2:15:00 PM | Browse: 2154 | Download: 1455